Chinese Journal of Pharmacovigilance ›› 2015, Vol. 12 ›› Issue (7): 444-444.
Previous Articles Next Articles
XI Yu-fei, XU Qin-fen, LI Xiao-yu, et al
Received:2015-09-01
Revised:2015-09-01
Online:2015-07-08
Published:2015-09-02
CLC Number:
XI Yu-fei, XU Qin-fen, LI Xiao-yu, et al. One Case of Acute Myocardial Infarction Induced by Allergy to Moxifloxacin Tablets[J]. Chinese Journal of Pharmacovigilance, 2015, 12(7): 444-444.
| [1] 张倩,张海涛. Kounis综合征研究进展[J]. 中国分子心脏病学杂志, 2013,13(4):643-646. [2] Kounis N G, Zavras G M. Histamine-induced coronary artery spasm: the concept of allergic angina[J]. Br J Clin Pract,1991, 45(2):121-128. [3] Rico Cepeda P, Palencia Herrejón E, Rodríguez Aguirregabiria M M. Kounis syndrome[J]. Med Intensiva,2012,36(5):358-364. [4] Kounis N G. Coronary hypersensitivity disorder: the kounis syndrome[J]. Clin Ther,2013, 35(5):563-571. [5] Tavil Y, Turfan M, Abaci A, et al. Kounis syndrome secondary to amoxicillin/clavulanic acid use[J]. Int J Cardiol,2008,124(1): e4-e7. [6] Calogiuri G F, Nettis E, Di Leo E, et al. Kounis syndrome induced by intravenous administration of piperacillin/tazobactam: A case report[J]. Int J Cardiol,2012,155(3): e42-e44. |
| [1] | SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126. |
| [2] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [3] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [4] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [5] | ZHANG Liangliang, HU Changkun, WU Zekun, ZHOU Wei, LIAO Zebin, GAO Yue. Protective effect and mechanism of dimethyl fumarate against intestinal radiation injury [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 83-88. |
| [6] | KE Bingbing, LI Yan, WANG Pinghui, XU Xiaoling, SHEN Jiate, LYU Xiaojun. Evaluation of anaphylactoid reactions induced by human immunoglobulin for intravenous injection(pH 4.0) based on mouse auricular blue staining experiments [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1357-1361. |
| [7] | WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei. Acute toxicity of proline Danshensu borneol ester in mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757. |
| [8] | LIU Jie, LIU Shengwei, REN Zhongyang, DING Ling, CHEN Chang, HU Yi. Effects of Panax notoginseng on gene expressions in rats with cerebral ischemia-reperfusion injury based on bioinformatics [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 454-459. |
| [9] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, Li Guiping, WANG Daohan, LI Shuran, ZHANG Jingsheng, PANG Bo, XU Yingli, ZHOU Lirun, BAO Yanyan, CHEN Mengping, GUO Shanshan, CUI Xiaolan. Effect of Jinzhen oral liquid on the model of human coronavirus pneumonia and fever epidemic immature adult mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 248-252. |
| [10] | LIU Jing, WANG Feng, ZHANG Jingpu, MENG Jie, DAI Zhong, MA Shuangcheng. Toxic effect of Shujin Dingtong tablets on embryonic development of zebrafish [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 262-265. |
| [11] | WANG Shan, HUANG Jukai, WU Honghui, WEN Yalu, ZHANG Li, WANG Jianhua, YANG Xiaohui. Evaluation of a KKAy animal model of type 2 diabetes mellitus combined with nonalcoholic fatty liver disease [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 273-276. |
| [12] | LI Yuanyuan, LIU Shengwei, REN Zhongyang, DING Ling, LIU Jie, LIAO Yuan. Potential mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 967-972. |
| [13] | LIU Mengxing, LIU Yuan, YANG Min, LUO Ji, YU Mingli, WANG Junlong, CHEN Jie. Effects of pyrazinamide on lipid peroxidation in L02 cells [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 977-981. |
| [14] | ZHANG Haifei, YU Shanshan, CAO Jin, ZHANG Tianzhu, WU Dongkai, NI Yike, ZUO Conglin, HU Xiaomin. Features and Requirements of Non-clinical Toxic Evaluation of Inhalable Drugs [J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 570-574. |
| [15] | RAO Zhi, ZANG Kaihong, WANG Xiaohua, QIN Hongyan. Effects of Quercetin on Rat Isoniazide Metabolism via N-acetyltransferase Evaluation [J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 121-125. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
